Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (391-400 of 449) with videos related to

Pageof 45
Sort By:
Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.
Neurogenetics|November 19, 2011
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sampleChristina M Lill, Brit-Maren M Schjeide, Denis A Akkad, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Research Square|June 9, 2022
Metagenomic assessment of gut microbial communities and risk of severe COVID-19Peggy Lai, Long Nguyen, Daniel Okin, et al.
RMD Open|April 1, 2022
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapyDaniel Sidler, Alexander Born, Simeon Schietzel, et al.
Clinical & Translational Immunology|February 23, 2016
New insights into the phenotype of human dendritic cell populationsGeorgina Jane Clark, Fiona Kupresanin, Phillip Dieter Fromm, et al.
The American Journal of Cardiology|October 14, 2022
The Impact of Cognitive Impairment on Clinical Outcomes After Transcatheter Aortic Valve Implantation (from a Systematic Review and Meta-Analysis)Jackie Jia Lin Sim, Ryan Ruiyang Ling, Vernicia Shu Qi Neo, et al.
The Lancet. Oncology|June 15, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trialAlison C Tree, Victoria Hinder, Andrew Chan, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
The New England Journal of Medicine|October 16, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate CancerNicholas van As, Clare Griffin, Alison Tree, et al.
Pageof 45

Showing results (391-400 of 449) with videos related to

Sort By:
Pageof 45
Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.
Neurogenetics|November 19, 2011
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sampleChristina M Lill, Brit-Maren M Schjeide, Denis A Akkad, et al.
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Research Square|June 9, 2022
Metagenomic assessment of gut microbial communities and risk of severe COVID-19Peggy Lai, Long Nguyen, Daniel Okin, et al.
RMD Open|April 1, 2022
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapyDaniel Sidler, Alexander Born, Simeon Schietzel, et al.
Clinical & Translational Immunology|February 23, 2016
New insights into the phenotype of human dendritic cell populationsGeorgina Jane Clark, Fiona Kupresanin, Phillip Dieter Fromm, et al.
The American Journal of Cardiology|October 14, 2022
The Impact of Cognitive Impairment on Clinical Outcomes After Transcatheter Aortic Valve Implantation (from a Systematic Review and Meta-Analysis)Jackie Jia Lin Sim, Ryan Ruiyang Ling, Vernicia Shu Qi Neo, et al.
The Lancet. Oncology|June 15, 2025
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trialAlison C Tree, Victoria Hinder, Andrew Chan, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
The New England Journal of Medicine|October 16, 2024
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate CancerNicholas van As, Clare Griffin, Alison Tree, et al.
Pageof 45